Type 2 diabetes mellitus constitutes an enormous health burden in the United States, and despite the
increasing prevalence of this disease there are still major gaps in understanding the underlying causes.
Increasing evidence indicates that type 2 diabetes ensues when beta-cell secretion is insufficient for insulin
needs, and that the development of insulin resistance accelerates this process. Obesity is a common cause of
insulin resistance and this connection is mediated in part by increased levels of fatty acids in the circulation
of overweight individuals. Recent studies of cultured cells suggest that elevations of fatty acids may also be
detrimental to insulin secretion and islet growth. Moreover, these studies suggest a differential effect among
fatty acids, with saturated but not monounsaturated fatty acids leading to beta-cell damage. These interesting
findings have not been confirmed in vivo. Thus, high circulating levels of fatty acids could contribute to the
increased demand for, and decreased supply of, insulin that are the core problems leading to diabetes. In
the first cycle of this program project we demonstrated that ad libitum intake of a diet containing 20% of
calories as butter fat- a high saturated fat diet- caused rats to get obese, insulin resistant, and
hyperinsulinemic. They also developed glucose intolerance indicating that their beta-cell response was
inadequate to compensate for their increased insulin requirements. The overall goal of this application is to
determine whether increased fat content in the diet leads to beta-cell dysfunction and whether the specific types
of fatty acids consumed are important in this process. The central hypothesis guiding this application is that
the intake of high amounts of saturated fat in the diet impairs islet function and the ability to compensate for
insulin resistance. We will test this hypothesis by completing three specific aims: i) To determine the effects
of short- and long-term exposure to diets high in saturated or monounsaturated fatty acids on glucose
metabolism; 2) To determine the effects of dietary saturated fatty acids on beta-cell adaptation to increased
demand; 3) To determine the effects of varying ambient concentrations of mono- and saturated-fatty acids
on islet/p-cell function and lipid content. Completion of this project will extend a body of compelling in vitro
work to intact animals and provide important new information regarding the effect of diet on beta-cell function
and glucose tolerance. These translational studies are highly relevant to human disease and could form the
basis for clinical studies aimed at modifying diabetes risk.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
041064767
UEI
DZ4YCZ3QSPR5
Project Start Date
01-April-2006
Project End Date
30-April-2011
Budget Start Date
01-April-2006
Budget End Date
30-April-2007
Project Funding Information for 2006
Total Funding
$197,753
Direct Costs
$128,829
Indirect Costs
$68,924
Year
Funding IC
FY Total Cost by IC
2006
National Institute of Diabetes and Digestive and Kidney Diseases
$197,753
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2P01DK056863-06A1 0002
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2P01DK056863-06A1 0002
Patents
No Patents information available for 2P01DK056863-06A1 0002
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2P01DK056863-06A1 0002
Clinical Studies
No Clinical Studies information available for 2P01DK056863-06A1 0002
News and More
Related News Releases
No news release information available for 2P01DK056863-06A1 0002
History
No Historical information available for 2P01DK056863-06A1 0002
Similar Projects
No Similar Projects information available for 2P01DK056863-06A1 0002